Literature DB >> 20947266

Interfractional variations in the setup of pelvic bony anatomy and soft tissue, and their implications on the delivery of proton therapy for localized prostate cancer.

Alexei Trofimov1, Paul L Nguyen, Jason A Efstathiou, Yi Wang, Hsiao-Ming Lu, Martijn Engelsman, Scott Merrick, Chee-Wai Cheng, James R Wong, Anthony L Zietman.   

Abstract

PURPOSE: To quantify daily variations in the anatomy of patients undergoing radiation therapy for prostate carcinoma, to estimate their effect on dose distribution, and to evaluate the effectiveness of current standard planning and setup approaches employed in proton therapy.
METHODS: We used series of computed tomography data, which included the pretreatment scan, and between 21 and 43 in-room scans acquired on different treatment days, from 10 patients treated with intensity-modulated radiation therapy at Morristown Memorial Hospital. Variations in femur rotation angles, thickness of subcutaneous adipose tissue, and physical depth to the distal surface of the prostate for lateral beam arrangement were recorded. Proton dose distributions were planned with the standard approach. Daily variations in the location of the prescription isodose were evaluated.
RESULTS: In all 10 datasets, substantial variation was observed in the lateral tissue thickness (standard deviation of 1.7-3.6 mm for individual patients, variations of >5 mm from the planning computed tomography observed in all series), and femur rotation angle (standard deviation between 1.3° and 4.8°, with the maximum excursion exceeding 10° in 6 of 10 datasets). Shifts in the position of treated volume (98% isodose) were correlated with the variations in the lateral tissue thickness.
CONCLUSIONS: Analysis suggests that, combined with image-guided setup verification, the range compensator expansion technique prevents loss of dose to target from femur rotation and soft-tissue deformation, in the majority of cases. Anatomic changes coupled with the uncertainties of particle penetration in tissue restrict possibilities for margin reduction in proton therapy of prostate cancer.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20947266      PMCID: PMC3026870          DOI: 10.1016/j.ijrobp.2010.08.006

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  19 in total

1.  Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison.

Authors:  Alexei Trofimov; Paul L Nguyen; John J Coen; Karen P Doppke; Robert J Schneider; Judith A Adams; Thomas R Bortfeld; Anthony L Zietman; Thomas F Delaney; William U Shipley
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-05-21       Impact factor: 7.038

2.  Reducing the sensitivity of IMPT treatment plans to setup errors and range uncertainties via probabilistic treatment planning.

Authors:  Jan Unkelbach; Thomas Bortfeld; Benjamin C Martin; Martin Soukup
Journal:  Med Phys       Date:  2009-01       Impact factor: 4.071

3.  Prompt gamma-ray emission from biological tissues during proton irradiation: a preliminary study.

Authors:  J C Polf; S Peterson; G Ciangaru; M Gillin; S Beddar
Journal:  Phys Med Biol       Date:  2009-01-09       Impact factor: 3.609

4.  Comparison between the lateral penumbra of a collimated double-scattered beam and uncollimated scanning beam in proton radiotherapy.

Authors:  Sairos Safai; Thomas Bortfeld; Martijn Engelsman
Journal:  Phys Med Biol       Date:  2008-03-07       Impact factor: 3.609

5.  Observations on real-time prostate gland motion using electromagnetic tracking.

Authors:  Katja M Langen; Twyla R Willoughby; Sanford L Meeks; Anand Santhanam; Alexis Cunningham; Lisa Levine; Patrick A Kupelian
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-02-14       Impact factor: 7.038

6.  Interfractional prostate shifts: review of 1870 computed tomography (CT) scans obtained during image-guided radiotherapy using CT-on-rails for the treatment of prostate cancer.

Authors:  James R Wong; Zhanrong Gao; Minoru Uematsu; Scott Merrick; Nolan P Machernis; Timothy Chen; Chee Wai Cheng
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-09-09       Impact factor: 7.038

7.  First proton radiography of an animal patient.

Authors:  Uwe Schneider; Jürgen Besserer; Peter Pemler; Matthias Dellert; Martin Moosburger; Eros Pedroni; Barbara Kaser-Hotz
Journal:  Med Phys       Date:  2004-05       Impact factor: 4.071

8.  Inter- and intrafractional movement-induced dose reduction of prostate target volume in proton beam treatment.

Authors:  Myonggeun Yoon; Dongwook Kim; Dong Ho Shin; Sung Yong Park; Se Byeong Lee; Dae Yong Kim; Joo Young Kim; Hong Ryull Pyo; Kwan Ho Cho
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-01-30       Impact factor: 7.038

9.  The precision of proton range calculations in proton radiotherapy treatment planning: experimental verification of the relation between CT-HU and proton stopping power.

Authors:  B Schaffner; E Pedroni
Journal:  Phys Med Biol       Date:  1998-06       Impact factor: 3.609

10.  Patient study of in vivo verification of beam delivery and range, using positron emission tomography and computed tomography imaging after proton therapy.

Authors:  Katia Parodi; Harald Paganetti; Helen A Shih; Susan Michaud; Jay S Loeffler; Thomas F DeLaney; Norbert J Liebsch; John E Munzenrider; Alan J Fischman; Antje Knopf; Thomas Bortfeld
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-07-01       Impact factor: 7.038

View more
  18 in total

1.  Visualization of a variety of possible dosimetric outcomes in radiation therapy using dose-volume histogram bands.

Authors:  Alexei Trofimov; Jan Unkelbach; Thomas F DeLaney; Thomas Bortfeld
Journal:  Pract Radiat Oncol       Date:  2011-09-09

Review 2.  Proton beam radiation therapy for prostate cancer-is the hype (and the cost) justified?

Authors:  Phillip J Gray; Jason A Efstathiou
Journal:  Curr Urol Rep       Date:  2013-06       Impact factor: 3.092

Review 3.  Proton beam and prostate cancer: An evolving debate.

Authors:  Anthony Zietman
Journal:  Rep Pract Oncol Radiother       Date:  2013-07-03

4.  Evaluation of the dosimetric impact of interfractional anatomical variations on prostate proton therapy using daily in-room CT images.

Authors:  Yi Wang; Jason A Efstathiou; Gregory C Sharp; Hsiao-Ming Lu; I Frank Ciernik; Alexei V Trofimov
Journal:  Med Phys       Date:  2011-08       Impact factor: 4.071

5.  The influence of patient positioning uncertainties in proton radiotherapy on proton range and dose distributions.

Authors:  Jakob Liebl; Harald Paganetti; Mingyao Zhu; Brian A Winey
Journal:  Med Phys       Date:  2014-09       Impact factor: 4.071

6.  Hypofractionated proton therapy for prostate cancer: dose delivery uncertainty due to interfractional motion.

Authors:  Yi Wang; Jason A Efstathiou; Hsiao-Ming Lu; Gregory C Sharp; Alexei Trofimov
Journal:  Med Phys       Date:  2013-07       Impact factor: 4.071

7.  Bone marrow sparing in intensity modulated proton therapy for cervical cancer: Efficacy and robustness under range and setup uncertainties.

Authors:  Eric Dinges; Nicole Felderman; Sarah McGuire; Brandie Gross; Sudershan Bhatia; Sarah Mott; John Buatti; Dongxu Wang
Journal:  Radiother Oncol       Date:  2015-05-13       Impact factor: 6.280

Review 8.  Clinical controversies: proton therapy for prostate cancer.

Authors:  Kent W Mouw; Alexei Trofimov; Anthony L Zietman; Jason A Efstathiou
Journal:  Semin Radiat Oncol       Date:  2013-04       Impact factor: 5.934

9.  Maximizing the biological effect of proton dose delivered with scanned beams via inhomogeneous daily dose distributions.

Authors:  Chuan Zeng; Drosoula Giantsoudi; Clemens Grassberger; Saveli Goldberg; Andrzej Niemierko; Harald Paganetti; Jason A Efstathiou; Alexei Trofimov
Journal:  Med Phys       Date:  2013-05       Impact factor: 4.071

10.  Fast range-corrected proton dose approximation method using prior dose distribution.

Authors:  Peter C Park; Joey Cheung; X Ronald Zhu; Narayan Sahoo; Laurence Court; Lei Dong
Journal:  Phys Med Biol       Date:  2012-05-16       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.